Pharma Mar SA (PHMMF)
87.58
0.00 (0.00%)
USD |
OTCM |
Aug 24, 16:00
Pharma Mar EPS Diluted (Quarterly) : -0.0652 for June 30, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.0652 |
| March 31, 2026 | 0.1033 |
| December 31, 2025 | 3.978 |
| September 30, 2025 | -0.2749 |
| June 30, 2025 | 1.507 |
| March 31, 2025 | -0.2365 |
| December 31, 2024 | 1.134 |
| September 30, 2024 | 0.2431 |
| June 30, 2024 | 0.0755 |
| March 31, 2024 | 0.1415 |
| December 31, 2023 | -0.4157 |
| September 30, 2023 | 0.092 |
| June 30, 2023 | 0.3042 |
| March 31, 2023 | 0.0836 |
| December 31, 2022 | 0.3371 |
| June 30, 2022 | 0.7617 |
| March 31, 2022 | 1.361 |
| December 31, 2021 | 2.422 |
| September 30, 2021 | 0.7483 |
| June 30, 2021 | 1.27 |
| March 31, 2021 | 0.00 |
| December 31, 2020 | 0.406 |
| September 30, 2020 | 0.091 |
| June 30, 2020 | 2.574 |
| March 31, 2020 | 4.203 |
| Date | Value |
|---|---|
| December 31, 2019 | 0.9333 |
| September 30, 2019 | -0.3409 |
| June 30, 2019 | -0.5284 |
| March 31, 2019 | -0.6456 |
| December 31, 2018 | -0.1918 |
| September 30, 2018 | -0.9163 |
| June 30, 2018 | 0.1966 |
| March 31, 2018 | -0.0876 |
| December 31, 2017 | -0.7719 |
| September 30, 2017 | -0.4446 |
| June 30, 2017 | -0.2958 |
| March 31, 2017 | -0.1416 |
| December 31, 2016 | -0.4385 |
| September 30, 2016 | -0.2055 |
| June 30, 2016 | -0.3686 |
| March 31, 2016 | -0.4248 |
| December 31, 2015 | -0.0657 |
| September 30, 2015 | 0.00 |
| June 30, 2015 | 0.00 |
| March 31, 2015 | 0.3971 |
| December 31, 2014 | -0.2998 |
| September 30, 2014 | 0.0552 |
| June 30, 2014 | -0.0109 |
| March 31, 2014 | 1.250 |
| December 31, 2013 | -0.1634 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Oryzon Genomics SA | -0.0022 |
| Grifols SA | 0.2631 |
| ACADIA Pharmaceuticals, Inc. | 0.1822 |
| Alkermes Plc | 0.0029 |
| Alnylam Pharmaceuticals, Inc. | 1.207 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -1.130M |
| Revenue (Quarterly) | 57.68M |
| Total Expenses (Quarterly) | 58.81M |
| Enterprise Value | 1.378B |
| Gross Profit Margin (Quarterly) | 86.21% |
| Profit Margin (Quarterly) | -1.96% |
| Earnings Yield | 4.27% |
| Operating Earnings Yield | 2.42% |
| Normalized Earnings Yield | 4.272 |